/rueziffra.com/Allan Ziffra-Pharmaceutical Litigation Attorney/ 04/24/2009
In April of 2008, the pharmaceutical company Actavis Totowa issued a nationwide recall of all lots of Digitek distributed by Mylan Pharmaceuticals due to the risk that these pills may contain a hazardous double-dose of the active ingredient digoxin. The Digitek recall was Class I in nature, meaning that the drug in question has the potential to cause death or serious health complications. The specific defect in the recalled lots of Digitek was that the tablets were manufactured at twice their intended size. Accordingly, these tablets contained double the approved level of digoxin which has led to dangerous overdoses in many consumers.
Digitek is designed to treat congestive heart failure and abnormal heart rhythms. However, when patients consume more than the prescribed amount of this drug, a condition known as digitalis toxicity can occur. This form of toxicity can be caused by consuming the recalled double-strength Digitek tablets. Symptoms of digitalis toxicity include:
Many Digitek consumers were notified of the recall by their pharmacies subsequent to the April 2008 news. If a family member has died due to heart/cardiac complications, find out if they were taking Digitek during the time period leading up to their death. If you or a loved one was prescribed a recalled lot of Digitek and suffered harm, contact the product liability and medical malpractice attorneys at Rue & Ziffra, P.A. Our law offices can be reached at 1-888-246-8613. Alternatively, visit Florida Product Liability Lawyers / Pharmaceutical Litigation Attorneys Rue & Ziffra website at www.RueZiffra.com for more information on the nationwide Digitek recall and the ways in which our legal team can help you achieve the compensation you deserve.Press Release Contact Information: Central Florida Pharmaceutical Litigation Attorney Rue & Ziffra